This conference is unique in the cell/gene therapy field, as it is focused on the technological challenges and engineering solutions for the robust and cost-effective manufacturing of cell and gene therapies. Moreover, owing to the restricted number of participants (~400), welcoming location and overall format, this conference is a valuable opportunity to showcase new and existing approaches with key academic and industrial leaders. In addition to a comprehensive series of oral sessions speakers from academic and industrial groups, we have designed the conference to foster networking and facilitate informal discussion around key engineering advances and issues. This will be enabled via several poster sessions, informal drinks and a focused workshop on viral manufacturing challenges & next generation technologies.